Clinical trial Recruiting at 1 site Interventional Ages 4 to 12

Digital management of children's asthma with connected inhalers and video visits

Official title: Towards Digital Management of Pediatric Asthma:a Pilot Study

Run by Assistance Publique - Hôpitaux de Paris · NCT06902766 · Data updated 2026-11-12

This pilot will test whether connected inhalers that trigger doctor video consultations can help manage asthma in children aged 4–12 compared with usual care.

More Pediatric Asthma trials

Quick facts

Study typeInterventional
Ages4 Years to 12 Years
SexAll
Enrollment50 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedNovember 25, 2025
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedOctober 16, 2026
Trial IDNCT06902766 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4–12 with physician-diagnosed asthma at GINA steps 2–4 who use pMDIs, are followed by a pediatrician or pediatric pulmonologist, have social security, and have a household smartphone with parental consent and ability to use the app.

Probably not a fit

Children with other significant pulmonary diseases, those who use non-pMDI inhaler devices, lack a compatible smartphone or parental ability to use the app, or whose asthma severity falls outside GINA steps 2–4 are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this 8-month pilot, 50 children aged 4–12 with physician-diagnosed asthma will be followed. Half will use connected pMDI inhaler devices that track controller and rescue use and send alerts to clinicians, and half will receive standard in-person care. Alerts for missed controller doses or frequent rescue use can prompt scheduled video consultations to adjust treatment. The study will measure feasibility and acceptability to families and clinicians and explore effects on asthma control, quality of life, and healthcare use to inform a larger trial.

Why it matters

Potential benefit: If successful, this approach could allow earlier remote treatment adjustments that reduce symptoms and healthcare visits while making care more convenient for families.

How similar studies have gone: Similar smart-inhaler and telemonitoring programs have shown promising but preliminary improvements in adherence and outcomes in adult and some pediatric cohorts, so the approach is not entirely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 4 to 12, whose asthma has been diagnosed by a physician
* Followed up for their asthma by a pediatrician or pediatric pulmonologist
* With asthma severity corresponding to GINA grades 2, 3 or 4 (Global Asthma Initiative Guidelines)
* Whose controller and reliever treatments are administered using pressurized metered-dose inhalers (p-MDIs)
* With social security
* Whose parents or legal guardian(s):

  * Have given their written and informed consent for their child's participation and their participation,
  * Have a smartphone in the household that can download the application and is compatible with it,
  * Are capable, in the opinion of the investigator, of understanding the use of the mobile application and module FRENCH CARE specifically dedicated to the research and the digital inhalers provided.

Non-inclusion Criteria:

* Patients with another pathology that could interfere with the evaluation of the endpoints (e.g, bronchopulmonary dysplasia, cystic fibrosis, etc.)
* Patients whose parents or legal representative(s) are, in the opinion of the investigator, unable to understand the purpose of the study and/or express their consent.
* Patients benefiting from State Medical Aid

Exclusion Criteria:

\- Patient who did not use the system within 15 days of the inclusion visit

Where it's running

  • Hôpital Necker Enfants Malades AP-HP
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: David DUMMOND, MD, PhD — Hôpital Necker Enfants Malades AP-HP
  • Study coordinator: David DUMMOND, MD, PhD
  • Email: david.drummond@aphp.fr
  • Phone: 01 87 89 20 28

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.